Page 53 - EJMO-9-3

Eurasian Journal of
Medicine and Oncology NOTCH3 in CSVD and breast cancer

Acknowledgments subpopulations in incidental cerebral white matter
hyperintensities: A multimodal study. Brain Sci. 2021;11:133.
We would like to acknowledge Ajman University for the
financial support. doi: 10.3390/brainsci11020133
6. Hu C, Dievart A, Lupien M, Calvo E, Tremblay G, Jolicoeur P.
Funding Overexpression of activated murine Notch1 and Notch3 in
Financial support for the article processing charge was transgenic mice blocks mammary gland development and
provided by Ajman University, UAE. induces mammary tumors. Am J Pathol. 2006;168:973-990.
doi: 10.2353/ajpath.2006.050416
Conflict of interest
7. Choy L, Hagenbeek TJ, Solon M, et al. Constitutive
The authors declare they have no competing interests NOTCH3 signalling promotes the growth of basal breast
cancers. Cancer Res. 2017;77(6):1439-1452.
Author contributions
doi: 10.1158/0008-5472.CAN-16-1022
Conceptualization: Che Mohd Nasril Che Mohd Nassir 8. Xiao Y, Ye Y, Zou X, et al. The lymphovascular embolus of
Formal analysis: Che Mohd Nasril Che Mohd Nassir inflammatory breast cancer exhibits a Notch 3 addiction.
Investigation: Zaw Myo Hein, Che Mohd Nasril Che Mohd Oncogene. 2011;30(3):287-300.
Nassir
Methodology: Che Mohd Nasril Che Mohd Nassir doi: 10.1038/onc.2010.405
Writing – original draft: Che Mohd Nasril Che Mohd Nassir 9. Feng Y, Spezia M, Huang S, et al. Breast cancer development
Writing – review & editing: All authors and progression: Risk factors, cancer stem cells, signalling
pathways, genomics, and molecular pathogenesis. Genes
Ethics approval and consent to participate Dis. 2018;5(2):77-106.

Not applicable. doi: 10.1016/j.gendis.2018.05.001
10. Henry NL, Shah PD, Haider I, Freer PE, Jagsi R, Sabel MS.
Consent for publication Cancer of the breast. In: Niederhuber JE, Armitage JO,

Not applicable. Doroshow JH, Kastan MB, Tepper JE, editors. Abeloff’s Clinical
Oncology. 6 ed. Philadelphia, PA: Elsevier; 2020.
th
Availability of data 11. Jagsi R, King TA, Lehman C, Morrow M, Harris JR,
Not applicable. Burstein HJ. Malignant tumors of the breast. In: DeVita
VT, Lawrence TS, Rosenberg SA, editors. DeVita, Hellman,
References and Rosenberg’s Cancer: Principles and Practice of Oncology.
11 ed. Philadelphia, PA: Lippincott Williams & Wilkins;
th
1. Kim K, Lee JH. Risk factors and biomarkers of ischemic 2019.
stroke in cancer patients. J Stroke. 2014;16(2):91-96.
st
12. Saunders C, Jassal S. Breast Cancer. 1 ed., Ch. 13. Oxford:
doi: 10.5853/jos.2014.16.2.91 Oxford University Press; 2009.
2. Quintas S, Rogado J, Gullón P, et al. Predictors of unknown 13. Fakhri N, Chad MA, Lahkim M, et al. Risk factors for
cancer in patients with ischemic stroke. J Neurooncol. breast cancer in women: An update review. Med Oncol.
2018;137(3):551-557. 2022;39(12):197.
doi: 10.1007/s11060-017-2741-0 doi: 10.1007/s12032-022-01804-x
3. Muiño E, Gallego-Fabrega C, Cullell N, et al. Systematic 14. Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer
review of cysteine-sparing NOTCH3 missense mutations in incidence and mortality rates and trends-an update. Cancer
patients with clinical suspicion of CADASIL. Int J Mol Sci. Epidemiol Biomark Prev. 2016;25(1):16-27.
2017;18:1964.
doi: 10.1158/1055-9965.EPI-15-0578
doi: 10.3390/ijms18091964
15. World Health Organization (WHO). Breast Cancer; 2023.
4. Dupré N, Drieu A, Joutel A. Pathophysiology of cerebral Available from: https://www.who.int/news-room/fact-
small vessel disease: A journey through recent discoveries. sheets/detail/breast-cancer [Last accessed on 2025 May .
19
J Clin Invest. 2024;134(10):e172841.
16. Sharma R. Breast cancer incidence, mortality and mortality-
doi: 10.1172/JCI172841
to-incidence ratio (MIR) are associated with human
5. Che Mohd Nassir CMN, Mohamad Ghazali M, Ahmad development, 1990-2016: Evidence from Global Burden of
Safri A, et al. Elevated circulating microparticle Disease Study 2016. Breast Cancer. 2019;26:428-445.

Volume 9 Issue 3 (2025) 45 doi: 10.36922/EJMO025150095